Panopoulos, A.D., et al.,The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming
It is noteworthy that the disruption of tight junctions is not only a result of inflammation but may also be an early event in the pathogenesis of IBD
A medically supervised weight loss program may help support improvements in: Healthy body weight and body composition Appetite control and reduced cravings Blood sugar regulation Insulin resistance Blood pressure Cholesterol levels Energy and daily activity Overall wellness and quality of life For many patients, losing weight can also reduce the impact of obesity-related conditions such as type 2 diabetes, high blood pressure, heart disease, metabolic syndrome, and certain sleep-related concerns
Studies showed influences on growth hormone secretion, prolactin levels, cortisol/corticosterone rhythms, luteinizing hormone, and possibly other pituitary and peripheral hormones
Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists
